News
Genoskin launches HistoSkin® FFPE skin tissue blocks
HistoSkin® FFPE skin tissue blocks In order to help our customers conduct the skin research they need, Genoskin launches HistoSkin® to simplify access to FFPE human skin tissue blocks and sections for studies and analysis. HistoSkin® offers a wide range of fully characterized FFPE tissue blocks and sections and provides new research opportunities involving human skin. A wide selection of donors Every year, Genoskin collects a wide range
Boston-Paris Biotechnology Summit
Genoskin to attend Boston-Paris Biotechnology Summit In order to better serve our American customers, Genoskin plans to set up a production unit in Boston in 2018. Our project has recently been selected by the NETVA program, which helps companies prepare for this strategic move. In May, we will attend the Boston-Paris Biotechnology Summit, an independent conference supported by a panel of biotech professionals from both sides of the
Genoskin invited to MEDEF meeting on how CEOs can drive change
Every year, the MEDEF, France’s largest entrepreneurial organisation, sets up local conferences in an attempt to bring companies together under a predefined theme. This year, Genoskin was invited to the 7th Edition of the Entrepreneurial Event (Grande Tribune des Entrepreneurs) to contribute to the discussion on the role of CEOs in driving change. The widely attended conference was headed by Pierre Gataz, the MEDEF’s president (see
CEO Innovation Award
On March 9th, 2017, Genoskin won the Award for Innovation at the CEO Company Challenge meeting in Colomiers, France. The award highlights local companies that have special merit in the area of export, innovation and job creation. Genoskin wins CEO Award for Innovation In the light of today’s challenging economic context, the CEO West-Toulouse Company Club aims to highlight the driving efforts of
US Patent for human skin models
Genoskin obtains US patent for skin models Genoskin is pleased to announce the approval of a US patent for our “system for the maintenance and survival of skin biopsies in transport and its applications”. The patent describes our method to transform human skin biopsies in ready-to-use and functional ex vivo skin models. The human skin biopsies that are used in our models
Genoskin finalist of Start-Up Connexion 2017
On February 3, 2017, Genoskin was awarded a finalist spot in the third edition of the Start-up Connexion Contest. This event brings together innovative research companies and potential investors to highlight and finance projects with high economic value. The Start-up Connexion Contest is a combined initiative of the CNRS (French National Center for Scientific Research) and the AEF Media Group, which specializes in
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
